B. Benacerraf, Use of sonographic markers to determine the risk of Down syndrome in second-trimester fetuses., Radiology, vol.201, issue.3, pp.619-620, 1996.
DOI : 10.1148/radiology.201.3.8939206

P. Pandya, R. Snijders, S. Johnson, M. Brizot, and K. Nicolaides, Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, BJOG: An International Journal of Obstetrics and Gynaecology, vol.305, issue.12, pp.957-962, 1995.
DOI : 10.1016/S0140-6736(86)91218-3

I. Merkatz, H. Nitowsky, J. Macri, and W. Johnson, An association between low maternal serum ??-fetoprotein and fetal chromosomal abnormalities, American Journal of Obstetrics and Gynecology, vol.148, issue.7, pp.886-894, 1984.
DOI : 10.1016/0002-9378(84)90530-1

M. Bogart, M. Pandian, and O. Jones, Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenatal Diagnosis, vol.98, issue.9, pp.623-630, 1987.
DOI : 10.1002/pd.1970070904

N. Wald, H. Cuckle, and J. Densem, Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome, BJOG: An International Journal of Obstetrics and Gynaecology, vol.26, issue.4, pp.334-341, 1988.
DOI : 10.1016/S0140-6736(84)92389-4

N. Wald, H. Watt, and A. Hackshaw, Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second Trimesters, New England Journal of Medicine, vol.341, issue.7, pp.461-467, 1999.
DOI : 10.1056/NEJM199908123410701

J. Jameson and A. Hollenberg, 1993 Regulation of chorionic gonadotropin gene expression, Endocr Rev, vol.14, pp.203-221

S. Handwerger, The physiology of placental lactogen in human pregnancy, Endocrinol, vol.12, pp.329-336, 1991.

E. Alsat, J. Guibourdenche, D. Luton, and F. Frankenne, Human placental growth hormone, American Journal of Obstetrics and Gynecology, vol.177, issue.6, pp.1526-1534
DOI : 10.1016/S0002-9378(97)70103-0